Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
High 2.76 at 3:45 pm ET, low 2.33 at 10:45 am ET.
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.
No case yet. It builds on the next filing, report or 13F period.
Solana Co has no measured co-movers clearing our correlation floor, so only its SEC classification is shown.
SIC 6199, Finance Services, from each company's own filings. Largest first.
42 managers report a position worth $26.2M between them, and 8 of them hold 80% of it.
tall tick = annual report · 1 on record
Solana Co
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Finance Services
HSDT (Solana Co) has 0 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.